Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University Hospital Center of Martinique clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France register with University Hospital Center of Martinique as lead sponsor. Synced 16 Nov 2026
3Current trials
3Recruiting now
0Drugs in these trials
1Trial register
At a glance

University Hospital Center of Martinique is the lead sponsor of 3 current clinical trials in our France register. 3 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Systemic Lupus Erythematosus.

ClinicalTrials.gov trials by status

  • Recruiting3100%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by University Hospital Center of Martinique

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
NCT06365359 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus, Renal Disease
Observational Recruiting 2025-01 France
Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care
NCT06153589 · ClinicalTrials.gov ↗ · Debridement Care, Leg Ulcer, Leg Ulcers Venous
Not applicable Recruiting 2025-01 France
Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital
NCT06560372 · ClinicalTrials.gov ↗ · SAH (Subarachnoid Hemorrhage), Cerebral Vasospasm, Moderate Traumatic Brain Injury
Not applicable Recruiting 2024-11 France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in University Hospital Center of Martinique trials

10 conditions
Systemic Lupus Erythematosus1Renal Disease1Debridement Care1Leg Ulcer1Leg Ulcers Venous1Pain1SAH (Subarachnoid Hemorrhage)1Cerebral Vasospasm1Moderate Traumatic Brain Injury1Severe Traumatic Brain Injury1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in France33

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Systemic Lupus Erythematosus

SponsorTrials
The Children's Hospital of Zhejiang University School of Medicine4
Chongqing Precision Biotech3
University Hospital, Bordeaux3
University Hospital, Strasbourg, France3
Miltenyi Biomedicine2
Shenzhen MagicRNA Biotechnology2
Chinese SLE Treatment And Research Group2
Yipeng Liu2
Beeline Medicines Corporation1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1

Sponsors with the most current trials registered for this condition.

05

Questions about University Hospital Center of Martinique trials

How many clinical trials does University Hospital Center of Martinique sponsor?

University Hospital Center of Martinique is the lead sponsor of 3 current trials on ClinicalTrials.gov in our France register, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are University Hospital Center of Martinique trials recruiting?

Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.